FDA withdrawing approval of late-stage breast cancer drug (AHN)

(AHN) – The U.S. Food and Drug Administration (FDA) is backtracking on its decision to approve Avastin for treating women with late-stage breast cancer announcing on Thursday it is withdrawing approval of the drug

Read the original post by Andy